Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis. (29th March 2019)

Record Type:: Journal Article
Title:: Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis. (29th March 2019)
Main Title:: Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis
Authors:: Lentzsch, Suzanne
Lagos, Galina G.
Comenzo, Raymond L.
Zonder, Jeffrey A.
Pregja, Silva
Osman, Keren
Tsai, Wei-Yann
Landau, Heather
Sanchorawala, Vaishali
Abstract:
Is Part Of:: Amyloid. Volume 26(2019)Supplement 1
Journal:: Amyloid
Issue:: Volume 26(2019)Supplement 1
Issue Display:: Volume 26, Issue 1 (2019)
Year:: 2019
Volume:: 26
Issue:: 1
Issue Sort Value:: 2019-0026-0001-0000
Page Start:: 113
Page End:: 114
Publication Date:: 2019-03-29
Subjects:: Amyloidosis -- Periodicals
616.3995
Journal URLs:: http://informahealthcare.com/loi/amy ↗
http://informahealthcare.com ↗
DOI:: 10.1080/13506129.2019.1583200 ↗
Languages:: English
ISSNs:: 1350-6129
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0859.841173
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 17187.xml